COVID-19 临床试验:谁可能参与,为什么?
Kimberly A Fisher1,2, Mara M Epstein1, Ngoc Nguyen1
1Division of Health Systems Science, Department of Medicine, UMass Chan Medical School, Worcester, MA 01655, USA.
加入COVID-19临床试验的意愿与教育和信任有关. 弱势群体,包括种族少数群体和共和党人,表现出较少的意愿,强调需要更大的医疗保健系统信心.
科学领域:
- 临床研究 临床研究
- 公共卫生 公共卫生
- 健康差异 在健康上的差异
背景情况:
- 了解影响参与临床试验的因素对于推动医学研究至关重要.
- COVID-19 临床试验在招聘方面遇到了挑战,特别是在多样化的人口中.
研究的目的:
- 确定与愿意参加COVID-19治疗临床试验相关的因素.
- 探索支持和反对参与此类试验的理由.
主要方法:
- 在线和电话调查于2021年10月至11月对马萨诸塞州居民进行了调查.
- 多变量逻辑回归分析了与参与意愿相关的因素.
- 传统的内容分析检查了对参与的理由和反对理由的开放式响应.
主要成果:
- 在1071名受访者中,65.6%倾向于参加COVID-19治疗试验.
- 高等教育,对医疗保健的信任和对医生/家庭的依赖与增加的意愿有关.
- 较低的健康素养,识别为黑人或西班牙裔,以及识别为共和党人与意愿降低有关.
结论:
- 教育,信任和对医疗保健专业人员的依赖等因素显著影响参与COVID-19临床试验的意愿.
- 弱势群体和对医疗保健系统信心较低的人不太可能参与.
- 需要努力在历史上处于不利地位的群体中建立对医疗保健系统的信心,以改善研究参与.
更多相关视频
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
相关概念视频
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Longitudinal Research
Hazard Ratio
For example, in a clinical trial...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
